Author: Provenzani, Alessio; Polidori, Piera
Title: Covid-19 and drug therapy, what we learned Cord-id: 2t3g8ve8 Document date: 2020_5_7
ID: 2t3g8ve8
Snippet: COVID-19, the disease associated in December 2019 with the novel coronavirus SARS-CoV-2, was observed for the first time in China and then spread worldwide becoming pandemic. Currently, there is still no licensed specific antiviral treatment for the human coronavirus disease and a vaccine will not be ready soon. However, based on experience from the use of other antiviral agents to treat similar virusses, some treatment options have been tried with some efficacy. Clinical trials for future thera
Document: COVID-19, the disease associated in December 2019 with the novel coronavirus SARS-CoV-2, was observed for the first time in China and then spread worldwide becoming pandemic. Currently, there is still no licensed specific antiviral treatment for the human coronavirus disease and a vaccine will not be ready soon. However, based on experience from the use of other antiviral agents to treat similar virusses, some treatment options have been tried with some efficacy. Clinical trials for future therapies are still ongoing. In the meantime, prevention, control, active communication and investment in research are the only ways to overcome this challenge.
Search related documents:
Co phrase search for related documents- load reduction and lopinavir ritonavir: 1, 2, 3, 4
- load reduction and lung function: 1
- load reduction and lung tissue: 1, 2, 3, 4
- lopinavir ritonavir and lung function: 1, 2, 3, 4, 5
- lopinavir ritonavir and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8
Co phrase search for related documents, hyperlinks ordered by date